Shopping Cart
- Remove All
- Your shopping cart is currently empty
Amisulpride (DAN 2163) (trade name Solian) is an antipsychotic drug sold by Sanofi-Aventis. It is not approved for use in the United States, but is approved for use in Europe and Australia for the treatment of psychoses and schizophrenia. Additionally, it is approved in Italy for the treatment of dysthymia (under the brand name Deniban). Amisulpride is a selective dopamine antagonist.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $42 | In Stock | |
50 mg | $58 | In Stock | |
100 mg | $79 | In Stock | |
200 mg | $138 | In Stock | |
500 mg | $251 | In Stock | |
1 g | $372 | In Stock | |
1 mL x 10 mM (in DMSO) | $39 | In Stock |
Description | Amisulpride (DAN 2163) (trade name Solian) is an antipsychotic drug sold by Sanofi-Aventis. It is not approved for use in the United States, but is approved for use in Europe and Australia for the treatment of psychoses and schizophrenia. Additionally, it is approved in Italy for the treatment of dysthymia (under the brand name Deniban). Amisulpride is a selective dopamine antagonist. |
Targets&IC50 | D3 receptor:3.2 nM (Ki), D2 receptor:2.8 nM (Ki) |
Alias | DAN 2163 |
Molecular Weight | 369.48 |
Formula | C17H27N3O4S |
Cas No. | 71675-85-9 |
Smiles | C(NCC1N(CC)CCC1)(=O)C2=C(OC)C=C(N)C(S(CC)(=O)=O)=C2 |
Relative Density. | 1.2 g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | Ethanol: 65 mg/mL (175.9 mM) H2O: < 1 mg/mL (insoluble or slightly soluble) DMSO: 50 mg/mL (135.33 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO/Ethanol
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.